/
/
/

Indo US Bio-Tech Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)68.20
Volume (₹)28,300.00
High (₹)71.89
Upper Circuit81.54
Low (₹)66.10
Lower Circuit54.36
Prev Close67.95
52W High (₹)159.00
Price66.31
52W Low (₹)57.50

Share Market Cap & Key Ratios Overview

M.Cap (₹)138.82 Cr
Div. Yield (%)0.00
PE Ratio32.05
Debt to Equity0.40
Price to Book2.12
Book Value46.15
EPS (TTM)2.16
Face Value10.00
ROE (%)15.34

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
KSCLNSE
VENKEYSNSE
AVTNPLNSE
FRESHARA-STNSE
REGAALNSE
BSHSLNSE
MGELNSE
SHEETAL-SMNSE
KOTYARKNSE
NATHBIOGENNSE
INDOUSNSE
LTP
1W Low
1W High
Market cap (₹)
669.3-13.4 (-1.96%)
650
691.75
3,416Cr
1560.6+49.2 (3.26%)
1490
1571.90
2,162Cr
96.88+7.31 (8.16%)
87.06
99.50
1,436Cr
386.9+2.55 (0.66%)
367
400
951Cr
85.5-3.9 (-4.36%)
85.50
90.58
903Cr
85.59+0.8 (0.94%)
81.90
87.49
881Cr
17.09-0.29 (-1.67%)
16.90
17.70
564Cr
391.9+8.9 (2.32%)
365
392
466Cr
38.44+0.99 (2.64%)
36
40.85
416Cr
133.48+1.1 (0.83%)
130.52
135.95
250Cr
66.31-12.05 (-15.38%)
65.10
83.48
139Cr

Key Highlights of Indo US Bio-Tech Ltd Balance Sheet

Indo US Bio-Tech Ltd balance sheet discloses shareholders' funds of ₹20.05Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹20.05Cr, and the reserves and surplus of the company is ₹58.47Cr.

The company has its non-current liabilities with total liabilities of ₹97.15Cr as of 2025-03-31.

The current liabilities are ₹16.34Cr as of 2025-03-31. At the same time, current assets are ₹86.73Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of 0 and tangible assets of ₹10.23Cr, provided in the Indo US Bio-Tech Ltd financial statements.